Earnings Summary

Sio Gene Therapies, Inc.’s revenue jumped NaN% since last year same period to $0Mn in the Q4 2022. On a quarterly growth basis, Sio Gene Therapies, Inc. has generated NaN% jump in its revenue since last 3-months.

Sio Gene Therapies, Inc.’s net profit jumped 86.57% since last year same period to $-3.42Mn in the Q4 2022. On a quarterly growth basis, Sio Gene Therapies, Inc. has generated -13.29% fall in its net profits since last 3-months.

Sio Gene Therapies, Inc.’s net profit margin jumped NaN% since last year same period to -Inf% in the Q4 2022. On a quarterly growth basis, Sio Gene Therapies, Inc. has generated NaN% jump in its net profit margins since last 3-months.

Sio Gene Therapies, Inc.’s earning per share (EPS) estimates for the current quarter stand at 0.07 - a 133.33% jump from last quarter’s estimates.

Sio Gene Therapies, Inc.’s earning per share (EPS) estimates for the current year stand at 0.07.

Sio Gene Therapies, Inc.’s earning per share (EPS) jumped NaN% since last year same period to 0 in the Q1 2024. This indicates that the Sio Gene Therapies, Inc. has generated NaN% annual rate of jump in its earning per share (EPS) in the last 4 quarters.

Sio Gene Therapies, Inc. declared 0.44 dividend per share during the earnings announcement for Q1 2024.